Lifecome Biochemistry Co.,Ltd. (SHE:002868)
20.85
-0.37 (-1.74%)
Oct 14, 2026, 12:54 PM CST
Lifecome Biochemistry Revenue
Lifecome Biochemistry had revenue of 119.43M CNY in the quarter ending June 30, 2026, a decrease of -21.40%. This brings the company's revenue in the last twelve months to 470.43M, down -23.73% year-over-year. In the year 2025, Lifecome Biochemistry had annual revenue of 516.58M, down -20.45%. That makes Lifecome Biochemistry the 25,360th largest company in the world by revenue and 4,512th in China.
Revenue (ttm)
470.43M
Revenue Growth
-23.73%
P/S Ratio
7.01
Revenue / Employee
856.88K
Employees
549
Market Cap
3.24B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 516.58M | -132.79M | -20.45% |
| Dec 31, 2024 | 649.37M | 142.37M | 28.08% |
| Dec 31, 2023 | 507.00M | 177.15M | 53.71% |
| Jan 1, 2023 | 329.85M | -33.54M | -9.23% |
| Dec 31, 2021 | 363.39M | 55.24M | 17.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Baolingbao Biology | 2.85B |
| Xiangxue Pharmaceutical | 1.48B |
| Qingdao Vland Biotech INC. | 1.42B |
| Pulike Biological Engineering | 1.02B |
| Zhejiang East Asia Pharmaceutical | 990.47M |
| Guanhao Biotech | 361.40M |
| Jiangsu Bioperfectus Technologies | 310.89M |
| Shanghai Shen Lian Biomedical | 278.46M |